ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!PTPI Company Profile and Key Details
Petros Pharmaceuticals, Inc.
PTPI Stock Price Chart
Stock Price Today
Petros Pharmaceuticals, Inc. (PTPI) stock declined over -5.59%, trading at $0.13 on NASDAQ, down from the previous close of $0.13. The stock opened at $0.13, fluctuating between $0.12 and $0.13 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for the treatment of acute Peyronie's disease. The company markets its line of ED products in the form of vacuum erection device products. Petros Pharmaceuticals, Inc. is based in New York, New York.
Company Information
| Employees | 21 |
| Beta | 1.89 |
| Sales or Revenue | $5.82M |
| 5Y Sales Change% | -0.981% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
Frequently Asked Questions
Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) stock price is $0.13 in the last trading session. During the trading session, PTPI stock reached the peak price of $0.13 while $0.12 was the lowest point it dropped to. The percentage change in PTPI stock occurred in the recent session was -5.59% while the dollar amount for the price change in PTPI stock was -$0.01.
The NASDAQ listed PTPI is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. Petros Pharmaceuticals, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Mitchell S. Arnold M.B.A.
Vice President of Fin. & Chief Accounting Officer
Mr. John David Shulman
Executive Chairman
Mr. Keith F. Lavan
Advisor
Mr. John D. Shulman
Executive Chairman
Mr. Fady Boctor M.B.A.
Pres & Chief Commercial Officer
PTPI's closing price is 3.31% higher than its 52-week low of $0.12 where as its distance from 52-week high of $1.76 is -92.88%.
Number of PTPI employees currently stands at 21.
Official Website of PTPI is: https://www.petrospharma.com
PTPI could be contacted at phone 973 242 0005 and can also be accessed through its website. PTPI operates from 1185 Avenue of the Americas, New York, NY 10036, United States.
PTPI stock volume for the day was 5.57M shares. The average number of PTPI shares traded daily for last 3 months was 5.14M.
The market value of PTPI currently stands at $1.41M with its latest stock price at $0.13 and 11.32M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com